Ernakulam Consumer Commission orders Samaritan Heart Institute to pay ₹43,900 for denied bill

A life-saving injection, an unissued bill, and a ₹43,900 gap in reimbursement

The District Consumer Disputes Redressal Commission, Ernakulam, has ruled against Samaritan Heart Institute in a dispute that saw a cardiac patient lose his Employees' State Insurance (ESI) reimbursement claim simply because the hospital declined to issue an individual bill for a life-saving medicine. The three-member bench — President Shri D.B. Binu and Members Shri V. Ramachandran and Smt. Sreevidhia T.N. — held the hospital guilty of deficiency in service and unfair trade practice.

A workplace fall that led to a cardiac emergency

On January 25, 2017, O. Vinod Kumar of Kannur suffered a fall at his workplace and was taken to Samaritan Heart Institute, Ernakulam, where he was referred to the hospital's cardiologist. At admission, the complainant informed the hospital that he had ESI coverage and requested that proper documentation be maintained for reimbursement purposes. He was subsequently transferred to an ESI-affiliated hospital and later admitted to Aster Medicity, Ernakulam, which offered ESI facilities.

Mr. Kumar paid approximately ₹60,500 out of pocket toward his treatment. While the hospital credited ₹11,058 back to his account, it refused to issue an individual bill for Elaxim 40 mg — a thrombolytic injection worth ₹43,900 administered during the emergency. The hospital's stated reason: the medicine had been purchased in bulk, so a separate bill could not be generated. Instead, it suggested the complainant present a letter to the ESI department.

The ESI authorities, however, insisted on detailed bill documentation to process the claim. Left without the requisite bill, Mr. Kumar's reimbursement was denied entirely.

Hospital's defence: emergency treatment, proper invoicing already provided

Samaritan Heart Institute stoutly denied the allegations. It contended that the complainant was admitted with CAD-ACS-STEMI — a critical cardiac condition — and that Elaxim (Tenecteplase) was administered as emergency thrombolytic therapy to save his life, as the patient's family declined angioplasty. The hospital maintained that a detailed inpatient invoice with itemised breakup was issued on January 27, 2017, and that the complainant raised no objection at the time.

The hospital further argued that it was not on the ESI panel during the relevant period and that the demand for a separate purchase bill was "not legally sustainable." It also pointed to the delay — the complaint was filed more than a year and eight months after treatment — as evidence of mala fide intent.

Commission rejects bulk-purchase defence

The Commission found the hospital's reasoning untenable on all counts. It observed that the complainant had repeatedly sought the bill for his treatment and that the hospital's failure to provide an individual bill for the Elaxim injection directly resulted in the loss of his ESI reimbursement.

"As far as ESI is concerned, where the complainant is having insurance coverage, production of the bill is inevitable. The complainant had not received the insured amount due to the non-production of the treatment bill for which the opposite party is responsible."

The Commission also dismissed the bulk-purchase justification outright: "The statement of the opposite party that individual bills cannot be given since the purchase of the medicine is bulk in nature cannot be accepted."

The verdict: compensation plus costs

Partially allowing the complaint, the Commission directed Samaritan Heart Institute to:

  • Pay ₹43,900 to the complainant as the amount lost due to non-issuance of the bill;
  • Pay ₹5,000 as compensation for mental trauma, agony, and hardship suffered; and
  • Pay ₹5,000 towards the costs of the proceedings.

The hospital was directed to comply within 45 days of receiving the order. In case of default, the amounts of ₹43,900 and ₹5,000 shall carry interest at 9% per annum from the date of the order until full realisation.

Key Observations

  • "The statement of the opposite party that individual bills cannot be given since the purchase of the medicine is bulk in nature cannot be accepted."
  • "As far as ESI is concerned, where the complainant is having insurance coverage, production of the bill is inevitable."
  • "The complainant had not received the insured amount due to the non-production of the treatment bill for which the opposite party is responsible."

This ruling reinforces that hospitals cannot shield themselves behind administrative convenience when patient reimbursement entitlements are at stake. For insured patients, the obligation to provide itemised billing is not optional — it is a core component of due service, and its failure carries financial consequences.